Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report)'s share price shot up 5.5% during mid-day trading on Monday . The company traded as high as $2.17 and last traded at $2.11. 30,861 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 111,707 shares. The stock had previously closed at $2.00.
Incannex Healthcare Price Performance
The stock's 50 day moving average is $2.05 and its 200-day moving average is $2.34.
Incannex Healthcare (NASDAQ:IXHL - Get Free Report) last issued its earnings results on Monday, September 30th. The company reported ($0.39) earnings per share (EPS) for the quarter. The firm had revenue of $0.01 million for the quarter.
Institutional Trading of Incannex Healthcare
Institutional investors and hedge funds have recently modified their holdings of the business. Tidal Investments LLC bought a new position in Incannex Healthcare during the first quarter valued at approximately $1,520,000. Virtu Financial LLC purchased a new stake in Incannex Healthcare during the 1st quarter valued at $39,000. Finally, AdvisorShares Investments LLC lifted its holdings in shares of Incannex Healthcare by 57.1% during the 2nd quarter. AdvisorShares Investments LLC now owns 80,002 shares of the company's stock valued at $238,000 after buying an additional 29,087 shares during the period. Institutional investors own 0.43% of the company's stock.
Incannex Healthcare Company Profile
(
Get Free Report)
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Recommended Stories
Before you consider Incannex Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Incannex Healthcare wasn't on the list.
While Incannex Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
